NX Prenatal - About the company
NX Prenatal is a series A company based in Louisville (United States), founded in 2010 by Brian Brohman. It operates as a Provider of early warning blood tests for pregnancy complications. NX Prenatal has raised $5.76M in funding. The company has 57 active competitors, including 11 funded and 7 that have exited. Its top competitors include companies like Pregnolia, DotLab and Orchid.
Company Details
Provider of early warning blood tests for pregnancy complications. The company's assays leverage its proprietary NeXosome platform technology which enables the isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation.
- Website
- www.nxprenatal.com/
- Email ID
- *****@nxprenatal.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2010
Location
Louisville, United States
Stage
Series A
Total Funding
$5.76M in 5 rounds
Latest Funding Round
Investors
Ranked
11th among 57 active competitors
Employee Count
2 as on Aug 31, 2026
Legal entities associated with NX Prenatal
NX Prenatal is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
NX Prenatal Inc CIN: 462509964 , United States, Active | Dec 31, 2009 | - | - | - |
Sign up to download NX Prenatal's company profile
NX Prenatal's funding and investors
NX Prenatal has raised a total funding of $5.76M over 5 rounds. Its first funding round was on Nov 02, 2017. NX Prenatal has 10 institutional investors.
Here is the list of recent funding rounds of NX Prenatal:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 21, 2023 | 5761740 | Series A | 3548179 | 5922648 | 9993795 | 6532678 |
Oct 14, 2022 | 1730005 | Grant (prize money) | 5720907 | 9851427 | 5871250 | |
Nov 16, 2020 | 4876742 | Seed | 5696300 | 1899287 | 3891289 | 1298687 |
View details of NX Prenatal's funding rounds and investors
NX Prenatal's founders and board of directors
Founder? Claim ProfileThe founders of NX Prenatal is Brian Brohman. Brian Brohman and Gail S Page are the CEOs of NX Prenatal.
Here are the details of NX Prenatal's key team members:
- Brian Brohman: Co-Founder & Co-CEO of NX Prenatal.
- Gail S Page: Co-CEO of NX Prenatal.
View details of NX Prenatal's Founder profiles and Board Members
NX Prenatal's employee count trend
NX Prenatal has 2 employees as of Aug 26. Here is NX Prenatal's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NX Prenatal's Competitors and alternates
Top competitors of NX Prenatal include Pregnolia, DotLab and Orchid. Here is the list of Top 10 competitors of NX Prenatal, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Pregnolia 2015, Zurich (Switzerland), Public | Provider of device for predicting chances of preterm births | $10.2M | 56/100 | |
2nd | DotLab 2016, Branford (United States), Series A | Provider of a molecular diagnostic testing tool for endometriosis in women | $10M | 49/100 | |
3rd | Provider of a genetic test for determining the health risk of babies | $16.5M | 46/100 | ||
4th | DiamiR 2009, Monmouth Junction (United States), Funding Raised | Developer of minimally invasive diagnostic tests | - | 45/100 | |
5th | Developer of diagnostic tests to detect autoimmune and chronic diseases | $978K | 45/100 | ||
6th | Provista Diagnostics 2007, New York City (United States), Acquired | Molecular oncology diagnostics company | $41.8M | 44/100 | |
7th | NGeneBio 2015, Seoul (South Korea), Public | In vitro cancer diagnostic products | $12.9M | 44/100 | |
8th | Syrona Health 2018, Newcastle Upon Tyne (United Kingdom), Seed | Digital women's health management software for employers and individuals | $575K | 42/100 | |
9th | Genomic Prediction 2017, North Brunswick (United States), Deadpooled | Offers genomics tests for IVF health outcomes | $4.5M | 40/100 | |
10th | TAI Diagnostics 2013, Milwaukee (United States), Series A | Provider of diagnostic solutions for transplant patients | $21.1M | 38/100 | |
11th | NX Prenatal 2010, Louisville (United States), Series A | Provider of early warning blood tests for pregnancy complications | $5.76M | 38/100 |
Looking for more details on NX Prenatal's competitors? Click here to see the top ones
NX Prenatal's Investments and acquisitions
NX Prenatal has made no investments or acquisitions yet.
Reports related to NX Prenatal
Here is the latest report on NX Prenatal's sector:
News related to NX Prenatal
•
Shop Circle Raises $60M in Series B FundingFinSMEs•Feb 28, 2025•Circeus, NX Prenatal, i80 Group, GS Futures and 8 others
•
NX Prenatal Announces Positive Clinical Data from Landmark Preterm Birth Diagnostic StudyEIN Presswire•Feb 10, 2025•NX Prenatal
•
NX Prenatal Supports PREBIC Publication Highlighting Importance of 'Early' Testing and Intervention for PreEIN Presswire•Aug 06, 2024•NX Prenatal
•
•
NX Prenatal Appoints Paul Kortschak to Serve as Chief Executive OfficerEIN Presswire•Apr 18, 2024•NX Prenatal
•
•
•
•
NX Prenatal and Milu Labs Announce Strategic Collaboration to Commercialize Exosome-Based Preterm Birth Risk Test in AsiaPR Newswire•Jan 16, 2019•NX Prenatal
•
Expanding Applications of NX Prenatal's Exosome-Based Diagnostics Platform Presented at Key ConferencesPR Newswire•Nov 13, 2018•NX Prenatal
Are you a Founder ?
FAQs about NX Prenatal
Explore our recently published companies
- Longplay - 2026 founded, Unfunded company
- Lala Lajpat Rai College of Commerce and Economics - Mumbai based, 1972 founded, Unfunded company
- Healthcare in - Germany based, Unfunded company
- TYT Studio - Ahmedabad based, 2015 founded, Unfunded company
- Trex Utah - Springville based, Unfunded company
- EPG - Germany based, 1957 founded, Unfunded company